Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2975 AUD | -0.83% |
|
+2.59% | -13.77% |
02:42am | Immutep Secures Regulatory Clearance for Phase 1 Antibody Study in Autoimmune Diseases; Shares Up 3% | MT |
07-12 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.77% | 287M | |
+25.83% | 47.96B | |
+45.38% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Secures Regulatory Clearance for Phase 1 Antibody Study in Autoimmune Diseases; Shares Up 3%